Alternatives to Mybiotics Pharma
Mybiotics Pharma is a Microbiome tool: myBiotics Pharma develops innovative microbiome-based pharmabiotics and drugs using proprietary bacterial mixes and efficient delivery technologies. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Microbiome companies to Mybiotics Pharma
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Aummune53Life SciencesSan Diego, United States$10.0MDevelops a platform for individual drug customization using aptamers for cancer treatment.
- Website
Trobix Bio49Life SciencesSan Diego, United States$3.0MPioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.
- Website
EnteroBiotix48BiotechnologyGlasgow, United Kingdom$40.5MDeveloping microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.
- Website
mbiomics48BiotechnologyMunich, Germany$12.0MAdvancing scalable microbiome-based therapeutics for severe and chronic diseases.
- Website
Isomorphic Labs68Drug DiscoveryLondon, United Kingdom$4.7BAI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.
- Website
WuXi AppTec66Drug DiscoveryShanghai, China$40.0MGlobal CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.
- Website
Somite.ai63Life SciencesTel Aviv, Israel$57.1MAI-driven digital twin of embryo development for cell-based therapies.
- Website
Mammoth Biosciences63BiotechnologyBrisbane, United States$460.0MBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
- Website
Arrakis Bio48Life SciencesCambridge, United StatesArrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Ella Therapeutics47Life SciencesBoston, United StatesDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
- Website
VILYA62BIO + LIFE SCIENCESSan Francisco, United States$121.0MAI-powered platform for designing novel molecular structures for new medicines.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website
Upstream Bio61Life SciencesWaltham, United States$400.0MClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
- Website
Vizgen61BiotechnologyWaltham, United States$169.5MSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
- Website
Abcam61BiotechnologyCambridge, United Kingdom$256.9MGlobal supplier of life science research tools, including antibodies, reagents, and assays.
- Website
Immunyx Pharma46Life SciencesNew York, United StatesBiopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
Showing the 20 closest matches. See the rest on the Mybiotics Pharma profile.
Compare Mybiotics Pharma head to head
Side by side on what each one does, what it costs, and what real users report.